What's new

Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Status: Opinion

Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Status: Opinion

Feb 28, 2025 - 13:43
 0
Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Status: Opinion
Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Status: Opinion
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Kizfizo, temozolomide,...

Next Article

Human medicines European public assessment report (EPAR): Pelgraz Paediatric, pe...

Related Posts

Human medicines European public assessment report (EPAR): Omlyclo, omalizumab, Date of authorisation: 16/05/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0